Predict your next investment

Venture Capital
rccf.com

See what CB Insights has to offer

Investments

187

Portfolio Exits

52

Funds

8

About River Cities Capital Fund

River Cities Capital Funds is one of the most active and experienced growth equity funds in healthcare and information technology (IT). With nearly $500 million under management and more than 100 investments made, River Cities has established itself as a preferred partner among the entrepreneurial and private equity communities. River Cities seeks to invest in high-growth IT and healthcare companies that have a market-validated proposition. Its performance is driven by our ability to access, evaluate, consummate and build companies that can lead the transformation of specific market segments by pursuing large, established markets with disruptive technologies or service offerings that are significantly "better, faster, cheaper" than incumbent solutions.

River Cities Capital Fund Headquarter Location

221 East Fourth Street Suite 2400

Cincinnati, Ohio, 45202,

United States

513-621-9700

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing River Cities Capital Fund

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Find River Cities Capital Fund in 1 Expert Collection, including Agriculture Technology (Agtech).

A

Agriculture Technology (Agtech)

24 items

Companies that are using technology to make farms more efficient

Latest River Cities Capital Fund News

Seattle-based heart monitor maker Bardy Diagnostics raises $35.5M

Apr 16, 2019

(Bardy DIagnostics Photo) Seattle-based medical device company Bardy Diagnostics today announced a $35.5 million funding round led by River Cities Capital Fund. The company makes the Carnation Ambulatory Monitor (CAM), which is a small, lightweight heart monitor that can detect arrhythmia. Bardy said the money would be used to grow its platform by expanding its sales force and monitoring services, as well as to invest in augmented intelligence and visualization technologies. The series B funding round drew new investors HealthQuest Capital, Aperture Venture Partners, Aphelion Capital, Lumira Ventures and Rex Health Ventures. Bardy’s device, which is used to monitor more than 40,000 patients, competes with other non-invasive cardiac monitors such as the iRhythm Zio. The CAM is meant to be worn comfortably for a week, designed to lead to higher rates of patient compliance. Bardy claims that its device captures clearer and more accurate heart rhythms than competing ECG monitors. The Carnation Ambulatory Monitor, or CAM for short, is designed to be worn comfortably for approximately a week, with the goal of improving patient compliance. (Bardy Diagnostics Photo) “For nearly 60 years, standard ECG engineering practices have over-processed the heart’s electrical message to make machines’ ‘lives’ easier at the expense of losing details in the ECG,” CEO Dr. Gust Bardy said in a statement . “In essence, such legacy engineering doesn’t listen to what the heart is trying to tell us but rather tells the heart what we are willing to hear.” Dr. Bardy is a longtime cardiac electrophysiologist who also serves as a clinical professor of medicine, cardiology, at the University of Washington and is the director of the Seattle Institute for Cardiac Research. Dr. Bardy sold his previous company, Cameron Health, to Boston Scientific in 2012. Rik Vandevenne, managing director of River Cities Capital Funds, and Garheng Kong, managing director of HealthQuest Capital, were named to Bardy’s board of directors as a result of the new funding. The company recently expanded its reach to Canada through an alliance with JNC Medical, a medical technologies distributor based in Ottawa, Ontario. Seattle-based journalist James Thorne is an NYU business and economics journalism grad who has written for publications including Reuters, CNBC, and Financial Planning. Follow him on Twitter @jamescthorne .

River Cities Capital Fund Investments

187 Investments

River Cities Capital Fund has made 187 investments. Their latest investment was in Q'Apel Medical as part of their Unattributed VC on April 4, 2022.

CBI Logo

River Cities Capital Fund Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

4/4/2022

Unattributed VC

Q'Apel Medical

$29.9M

No

2

10/6/2021

Series D

Catalyst Orthoscience

$12.3M

No

7

8/31/2021

Series D

SPR Therapeutics

$37M

Yes

4

6/7/2021

Series C

Subscribe to see more

$99M

Subscribe to see more

10

6/1/2021

Series B

Subscribe to see more

$99M

Subscribe to see more

10

Date

4/4/2022

10/6/2021

8/31/2021

6/7/2021

6/1/2021

Round

Unattributed VC

Series D

Series D

Series C

Series B

Company

Q'Apel Medical

Catalyst Orthoscience

SPR Therapeutics

Subscribe to see more

Subscribe to see more

Amount

$29.9M

$12.3M

$37M

$99M

$99M

New?

No

No

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

2

7

4

10

10

River Cities Capital Fund Portfolio Exits

52 Portfolio Exits

River Cities Capital Fund has 52 portfolio exits. Their latest portfolio exit was Building Engines on October 21, 2021.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

10/21/2021

Acquired

$99M

3

10/14/2021

Acquired

$99M

3

8/6/2021

Acquired

$99M

15

5/24/2021

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

5/17/2021

Acquired

Subscribe to see more

Subscribe to see more

10

Date

10/21/2021

10/14/2021

8/6/2021

5/24/2021

5/17/2021

Exit

Acquired

Acquired

Acquired

Acquired

Acquired

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

Acquirer

Subscribe to see more

Subscribe to see more

Sources

3

3

15

10

10

River Cities Capital Fund Acquisitions

3 Acquisitions

River Cities Capital Fund acquired 3 companies. Their latest acquisition was Carolina Partners in Mental Healthcare on September 27, 2018.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

9/27/2018

$99M

Acq - Fin

2

4/15/2008

Private Equity

Subscribe to see more

$99M

$99M

Subscribe to see more

10

4/4/2008

Private Equity

Subscribe to see more

$99M

$99M

Subscribe to see more

10

Date

9/27/2018

4/15/2008

4/4/2008

Investment Stage

Private Equity

Private Equity

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

Total Funding

$99M

$99M

Note

Acq - Fin

Subscribe to see more

Subscribe to see more

Sources

2

10

10

River Cities Capital Fund Fund History

8 Fund Histories

River Cities Capital Fund has 8 funds, including River Cities Capital Fund VII.

Closing Date

Fund

Fund Type

Status

Amount

Sources

1/18/2022

River Cities Capital Fund VII

$161M

1

8/2/2019

River Cities Capital Fund VI

$99M

10

5/20/2014

River Cities Capital Fund V

Subscribe to see more

Subscribe to see more

$99M

10

12/19/2008

River Cities Capital Fund II

Subscribe to see more

Subscribe to see more

$99M

10

3/31/2008

River Cities Capital Fund IV

Subscribe to see more

Subscribe to see more

$99M

10

Closing Date

1/18/2022

8/2/2019

5/20/2014

12/19/2008

3/31/2008

Fund

River Cities Capital Fund VII

River Cities Capital Fund VI

River Cities Capital Fund V

River Cities Capital Fund II

River Cities Capital Fund IV

Fund Type

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Subscribe to see more

Subscribe to see more

Subscribe to see more

Amount

$161M

$99M

$99M

$99M

$99M

Sources

1

10

10

10

10

River Cities Capital Fund Team

7 Team Members

River Cities Capital Fund has 7 team members, including current Managing Director, Daniel T. Fleming.

Name

Work History

Title

Status

Daniel T. Fleming

Managing Director

Current

Rob Heiman

Managing Director

Current

Robert A. Heimann

The Brandery

Managing Director

Current

R. Glen Mayfield

Managing Director

Current

Edwin T. Robinson

Managing Director

Current

Name

Daniel T. Fleming

Rob Heiman

Robert A. Heimann

R. Glen Mayfield

Edwin T. Robinson

Work History

The Brandery

Title

Managing Director

Managing Director

Managing Director

Managing Director

Managing Director

Status

Current

Current

Current

Current

Current

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.